The most frequently studied variant in the SLC19A1 gene associated with congenital heart disease in humans is the missense mutation in the exon 2 of the gene, which results in an amino acid change on position 27 in the SLC19A1 protein; namely, histidine is replaced by proline (Table 2). Here, SLC19A1 is linked to congenital heart disease.